BVT Aktienanleihe RWE/ DE000VU5VCY9 /
| 6/21/2024 7:54:08 PM | Chg.-0.030 | Bid7:54:08 PM | Ask7:54:08 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 99.700EUR | -0.03% | - Bid Size: - |
- Ask Size: - |
RWE AG INH O.N. | - EUR | 6/28/2024 | Call |
GlobeNewswire
6/25
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
6/18
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
6/12
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
6/11
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
6/5
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
6/4
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
5/23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
5/20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
5/13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
5/2
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
4/25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
